MK-3207
≥98%
- Product Code: 101445
CAS:
957118-49-9
| Molecular Weight: | 557.59 g./mol | Molecular Formula: | C₃₁H₂₉F₂N₅O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
MK-3207 is primarily researched for its potential application in the treatment of migraines. It functions as a calcitonin gene-related peptide (CGRP) receptor antagonist, which plays a significant role in migraine pathophysiology. By blocking the CGRP receptor, MK-3207 aims to alleviate migraine symptoms and prevent migraine attacks. Clinical studies have explored its efficacy and safety in reducing the frequency and severity of migraines, making it a promising candidate for migraine management. Its development highlights the importance of targeting specific pathways in neurological disorders to improve patient outcomes.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $1,213.46 |
+
-
|
| 0.010 | 10-20 days | $2,413.86 |
+
-
|
MK-3207
MK-3207 is primarily researched for its potential application in the treatment of migraines. It functions as a calcitonin gene-related peptide (CGRP) receptor antagonist, which plays a significant role in migraine pathophysiology. By blocking the CGRP receptor, MK-3207 aims to alleviate migraine symptoms and prevent migraine attacks. Clinical studies have explored its efficacy and safety in reducing the frequency and severity of migraines, making it a promising candidate for migraine management. Its development highlights the importance of targeting specific pathways in neurological disorders to improve patient outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :